676 related articles for article (PubMed ID: 17068118)
1. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.
Li Z; Mizuno S; Nakamura T
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G639-46. PubMed ID: 17068118
[TBL] [Abstract][Full Text] [Related]
2. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor protects against Fas-mediated liver apoptosis in transgenic mice.
Suzuki H; Toyoda M; Horiguchi N; Kakizaki S; Ohyama T; Takizawa D; Ichikawa T; Sato K; Takagi H; Mori M
Liver Int; 2009 Nov; 29(10):1562-8. PubMed ID: 19725891
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice.
Wang H; Vohra BP; Zhang Y; Heuckeroth RO
Hepatology; 2005 Nov; 42(5):1099-108. PubMed ID: 16250054
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor stimulates the induction of cytokine-induced neutrophil chemoattractant through the activation of NF-kappaB in rat hepatocytes.
Kaibori M; Yanagida H; Nakanishi H; Ozaki T; Yoshida H; Matsui K; Hijikawa T; Kamiyama Y; Okumura T
J Surg Res; 2006 Jan; 130(1):88-93. PubMed ID: 16271365
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium.
Liu Z; Sakamoto T; Ezure T; Yokomuro S; Murase N; Michalopoulos G; Demetris AJ
Hepatology; 1998 Nov; 28(5):1260-8. PubMed ID: 9794910
[TBL] [Abstract][Full Text] [Related]
7. Yin-Chen-Hao-Tang ameliorates obstruction-induced hepatic apoptosis in rats.
Lee TY; Chang HH; Wu MY; Lin HC
J Pharm Pharmacol; 2007 Apr; 59(4):583-90. PubMed ID: 17430643
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats.
Inoue H; Yokoyama F; Kita Y; Yoshiji H; Tsujimoto T; Deguchi A; Nakai S; Morishita A; Uchida N; Masaki T; Watanabe S; Kuriyama S
Int J Mol Med; 2006 May; 17(5):857-64. PubMed ID: 16596271
[TBL] [Abstract][Full Text] [Related]
9. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
Wen YA; Liu D; Zhou QY; Huang SF; Luo P; Xiang Y; Sun S; Luo D; Dong YF; Zhang LP
Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor accelerates the proliferation of hepatic oval cells and possibly promotes the differentiation in a 2-acetylaminofluorene/partial hepatectomy model in rats.
Hasuike S; Ido A; Uto H; Moriuchi A; Tahara Y; Numata M; Nagata K; Hori T; Hayashi K; Tsubouchi H
J Gastroenterol Hepatol; 2005 Nov; 20(11):1753-61. PubMed ID: 16246197
[TBL] [Abstract][Full Text] [Related]
11. Changes in expression and immunolocalization of protein associated with toxic bile salts-induced apoptosis in rat hepatocytes.
Oh SH; Yun KJ; Nan JX; Sohn DH; Lee BH
Arch Toxicol; 2003 Feb; 77(2):110-5. PubMed ID: 12590363
[TBL] [Abstract][Full Text] [Related]
12. Tissue-type plasminogen activator deficiency exacerbates cholestatic liver injury in mice.
Wang H; Zhang Y; Heuckeroth RO
Hepatology; 2007 Jun; 45(6):1527-37. PubMed ID: 17538930
[TBL] [Abstract][Full Text] [Related]
13. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
Tamaki N; Hatano E; Taura K; Tada M; Kodama Y; Nitta T; Iwaisako K; Seo S; Nakajima A; Ikai I; Uemoto S
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G498-505. PubMed ID: 18174271
[TBL] [Abstract][Full Text] [Related]
14. Heparin-binding epidermal growth factor-like growth factor and hepatocyte growth factor inhibit cholestatic liver injury in mice through different mechanisms.
Sakamoto K; Khai NC; Wang Y; Irie R; Takamatsu H; Matsufuji H; Kosai KI
Int J Mol Med; 2016 Dec; 38(6):1673-1682. PubMed ID: 27779646
[TBL] [Abstract][Full Text] [Related]
15. Endogenous interferon gamma protects against cholestatic liver injury in mice.
Sewnath ME; Van Der Poll T; Van Noorden CJ; Ten Kate FJ; Gouma DJ
Hepatology; 2002 Dec; 36(6):1466-77. PubMed ID: 12447873
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor prevents pulmonary ischemia-reperfusion injury in mice.
Makiuchi A; Yamaura K; Mizuno S; Matsumoto K; Nakamura T; Amano J; Ito K
J Heart Lung Transplant; 2007 Sep; 26(9):935-43. PubMed ID: 17845933
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor reduces Fas-mediated acute liver injury in mice.
Tanaka Y; Sohda T; Matsuo K; Anan A; Irie M; Takeyama Y; Iwata K; Shakado S; Sakisaka S
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e207-11. PubMed ID: 17784864
[TBL] [Abstract][Full Text] [Related]
18. c-Met responsiveness of isolated hepatocytes evaluated in an in vitro de-differentiation model.
Boost KA; Kim HJ; Engl T; Oppermann E; Jonas D; Oertl A; Blaheta RA
Int J Mol Med; 2006 Mar; 17(3):475-82. PubMed ID: 16465395
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis.
Shimizu M; Hara A; Okuno M; Matsuno H; Okada K; Ueshima S; Matsuo O; Niwa M; Akita K; Yamada Y; Yoshimi N; Uematsu T; Kojima S; Friedman SL; Moriwaki H; Mori H
Hepatology; 2001 Mar; 33(3):569-76. PubMed ID: 11230736
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo bioactivity of recombinant canine hepatocyte growth factor.
Arends B; Spee B; Hoffmann G; Jansen GE; Slump E; Auriemma E; Ijzer J; Hemrika W; Romijn RA; van der Heijden-Liefkens KH; Sondermeijer PJ; van den Ingh TS; Penning LC; Rothuizen J
Vet J; 2008 Oct; 178(1):70-7. PubMed ID: 18314358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
